Oxytocin Hameln Pharma (Oxytocin)

Oxytocin is a peptide hormone that acts on the uterine smooth‑muscle and breast tissue pathways:

• Induction of labor: Facilitates cervical ripening and stimulates uterine contractions to initiate vaginal delivery.
• Post‑partum hemorrhage control: Promotes uterine contraction to reduce bleeding after delivery.
• Lactation support: Enhances milk ejection reflex by stimulating myo‑myoepithelial cells in the breast.
• Management of incomplete uterine atony at cesarean section (by direct myometrial injection).

• Oxytocin binds to oxytocin receptors, which are G‑protein‑coupled receptors located on uterine smooth‑muscle cells and myo‑myoepithelial cells of the breast. Receptor activation triggers intracellular calcium release, leading to muscle contraction in the uterus and milk‑ejection in the breast. The hormone’s short half‑life results from rapid enzymatic degradation by oxytocinases in the blood.

Oxytocin may cause a range of adverse reactions, most of which are dose‑dependent and related to its uterotonic activity.

Common Side Effects

• Nausea: Mild to moderate nausea reported during infusion.
• Headache: Transient headache occurring shortly after administration.
• Flushing: Warmth or redness of the skin, especially on the face.
• Uterine hyperstimulation: Excessive uterine contractions that may cause fetal distress.
• Hypotension: Lowered blood pressure due to vasodilation.

Serious or Rare Side Effects

• Cardiac arrhythmia: Irregular heart rhythm, particularly in patients with pre‑existing cardiac disease.
• Water intoxication: Hyponatyl‑related syndrome due to antidiuretic‑like effect at high doses.
• Severe uterine rupture: Rare tearing of the uterine wall, usually linked to over‑stimulation.
• Anaphylaxis: Immediate hypersensitivity reaction requiring emergency treatment.
• Pulmonary edema: Fluid accumulation in the lungs, especially with fluid overload.
• Seizures: Rare neurologic event associated with severe electrolyte imbalance.

Oxytocin should be administered only by qualified health‑care professionals in settings equipped for maternal‑fetal monitoring.

• Assess maternal cardiovascular status: Check blood pressure and heart rate before and during infusion.
• Monitor fetal heart rate: Continuous fetal monitoring is required during labor induction.
• Avoid high‑dose bolus: Use incremental dosing to reduce risk of uterine hyperstimulation.
• Use caution in patients with cardiac disease: Adjust dosing and monitor closely.
• Contraindicated in placenta previa or vasa previa: Do not use when placental location poses bleeding risk.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Oxytocin may interact with several medications that influence uterine tone or cardiovascular function.

Major Interactions (Avoid)

• Ergot alkaloids: May cause additive uterine hyperstimulation.
• Beta‑beta   ");